Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: NOT IN to NOTIN
  • Copy ADQRS QS Template pages to the Initial development (Not ready for internal review). Please DO NOT OVERWRITE the template pages.
  • Change the title of the page as follows:
  • Remove 'Copy of ADQRS QS Template - '. The new title should begin with 'ADaM ADQRS Short_Name...'.
  • Change 'ADQRS Short_Name' to the short name (QSCAT) for the current measure.
    1. This change needs to be done in the title as well as throughout the document.
  • The version number will be 'v1' if there has never been a supplement for the measure before. Otherwise, increment as appropriate.
  • When copyrighted instruments are used, 'Public domain' will need to be changed to 'Approved'. Note that the copyright approval must allow for the creation of analysis supplements.
  • Replace 'ADQRS Long_Name' and 'ADQRS Short_Name' with the long and short name of the measure that the supplement is being created for.
  • Replace royal blue text with information pertaining to the measure the supplement is being created for. Delete royal blue text which does not apply to the new measure. Unless otherwise noted, text in black applies to all QRS Questionnaire Supplements and should not be deleted.
  • Remove all information blocks, except for the one immediately below this called 'Information for Reviewers'.

  • Keep changes in blue for ease throughout internal and public review. Once the supplement has gone thru public review and all comments are resolved, change all text color to black except for hyperlinks.

  • Info
    titleInstructions on how to use this template
    Info
    titleInformation for Reviewers

    Text in black is part of the template used to create this document and is not under review. Please review the blue text; this text represents the changes made to the template that are specific to this QRS instrument.

    Page propertiesTitle

    Acute Physiology and Chronic Health Evaluation II Clinical Classification (APACHE II)

    CDISC ReferenceClinical Classification Supplement to the Analysis Data Model Implementation GuideQRS Short NameAPACHE IIADQRS Permission StatusPublic DomainTeamCDISC ADaM Questionnaires, Ratings, and Scales (QRS) SubteamSupplement Version1.0 (or higher as appropriate when doing a supplement revision)
    StatusDRAFT (or "REVISION DRAFT" or "FINAL", as appropriate). Status will not be considered "Final" until the supplement is ready to be sent for publication.Date2022 (date current version released, regardless of status)NotesThis supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Analysis Data Model Implementation Guide. Naming conventions follow ADaMIG v1.1 or higher.

    Revision History

    DateVersion2022  (update whenever text is modified below, even during development)1.0 Draft

    © 2022 Clinical Data Interchange Standards Consortium, Inc. All rights reserved.

    1     General Considerations

    Information for Reviewers

    Text in black is part of the template used to create this document and is not under review. Please review the blue text; this text represents the changes made to the template that are specific to this QRS instrument.

    Page properties
    Title

    Acute Physiology and Chronic Health Evaluation II Clinical Classification (APACHE II)

    CDISC ReferenceClinical Classification Supplement to the Analysis Data Model Implementation Guide
    QRS Short NameAPACHE II
    ADQRS Permission StatusPublic Domain
    TeamCDISC ADaM Questionnaires, Ratings, and Scales (QRS) Subteam
    Supplement Version1.0 (or higher as appropriate when doing a supplement revision)
    StatusDRAFT (or "REVISION DRAFT" or "FINAL", as appropriate). Status will not be considered "Final" until the supplement is ready to be sent for publication.
    Date2024-02-20
    NotesThis supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Analysis Data Model Implementation Guide. Naming conventions follow ADaMIG v1.1 or higher.


    Revision History

    DateVersion
    2024-02-201.0 Draft

    © 2024 Clinical Data Interchange Standards Consortium, Inc. All rights reserved.

    1     General Considerations

    This section describes the implementation of the analysis dataset for QRS instruments as based on the Basic Data Structure (BDS) described in the Analysis Data Model Implementation Guide (ADaMIG). The ADaMIG can be found on the CDISC website at https://www.cdisc.org/standards/foundational/adam. The BDS was chosen as the model for analysis datasets of QRS instruments because it supports a wide variety of analyses, including summaries of total score by timepoint as well as change from baseline by timepoint. This data structure allows the ADaM variables PARAM and PARAMCD to come directly from Study Data Tabulation Model (SDTM) variables RS.RSTEST and RS.RSTESTCD, respectively, for individually captured items, thus ensuring traceability between SDTM and ADaM data. If other analyses are required that are not supported by the BDS, then consideration would be needed as to the appropriate structure. Analysis requirements always drive the design of the analysis datasets.

    This ADaM supplement is based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) Clinical Classification Supplement Version 2.0 to the SDTM Implementation Guide for Human Clinical Trials (SDTMIG). 

    Note that source SDTM score values may not be suitable for analysis because the values may need to be imputed or transformed. In addition, recalculation of collected values may be needed per analysis rules. In these cases, the derivation of AVAL may not be a simple copying of RS.RSSTRESN. 

    These specific analysis implementation details for the APACHE II are meant to be used in conjunction with ADaMIG. All completed questionnaires, ratings, and scales documentation can be found on the CDISC website at: This section describes the implementation of the analysis dataset for QRS instruments as based on the Basic Data Structure (BDS) described in the Analysis Data Model Implementation Guide (ADaMIG). The ADaMIG can be found on the CDISC website at https://www.cdisc.org/standards/foundational/adam. The BDS was chosen as the model for analysis datasets of QRS instruments because it supports a wide variety of analyses, including summaries of total score by timepoint as well as change from baseline by timepoint. This data structure allows the ADaM variables PARAM and PARAMCD to come directly from Study Data Tabulation Model (SDTM) variables RS.RSTEST and RS.RSTESTCD, respectively, for individually captured questions, thus ensuring traceability between SDTM and ADaM data. If other analyses are required that are not supported by the BDS, then consideration would be needed as to the appropriate structure. Analysis requirements always drive the design of the analysis datasets.

    This ADaM supplement is based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) Clinical Classification Supplement Version 1.1 to the SDTM Implementation Guide for Human Clinical Trials (SDTMIG). 

    Note that source SDTM score values may not be suitable for analysis because the values may need to be imputed or transformed. In addition, recalculation of collected values may be needed per analysis rules. In these cases, the derivation of AVAL may not be a simple copying of RS.RSSTRESN. 

    ...

    qrs.

    1.1   Representations and Warranties, Limitations of Liability, and Disclaimers

    This document is a supplement to the ADaMIG and is covered under Appendix C of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix C of the ADaMIG for a complete version of this material.

    CDISC does not endorse any QRS instrument and does not specify how to conduct clinical assessments, protocols, or analyses. CDISC disclaims any liability for your use of this material.

    1.2   Copyright Status

    CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the APACHE II in the CDISC library of QRS data standards supplementsThere may be many versions of this instrument in the public domain or copyrighted. CDISC has chosen to use the version attached to the QRS supplement to the SDTMIG, and the QRS supplement to the ADaMIG is based on the same version.

    Note: CDISC Controlled Terminology is maintained by National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS). The most recent versions of the SDTM and ADaM controlled terminologies should be accessed through the CDISC website (https://www.cdisc.org/

    ...

    standards/

    ...

    terminology).

    1.

    ...

    3   Known Issues

    The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity of disease measurement and mortality estimation tool for adult subjects applied within 24 hours of admission to an intensive care unit (ICU). The instrument's intended use is for newly admitted subjects to the ICU. The instrument consists of individual items that are summed to create a total score. This instrument is generally collected once at Screening/Baseline. The total score is normally collected as part of the instrument with no instructions provided for handling missing data. In the majority of cases, where APACHE II is only assessed once and the collected total score used as a baseline covariate, the SDTM RS domain may be sufficient to support the analysis requirements. If this is the case, a variable in ADSL copied directly from a result/value in SDTM may be sufficient to support analysis needs.

    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-325

    The APACHE II total score is designed as a mortality prediction tool. It is not intended to influence the medical management or care of subjects during their ICU stay or to be calculated sequentially to show improvement or effect of interventions. The worst values recorded during the initial 24 hours in the ICU are recommended to be used in calculation of the total score but the measurements initially recorded during the subject’s admission can be used for practical reasons. 

    Although the APACHE II total score is the most widely used ICU mortality prediction score, it has a number of limitations and shortcomings. The total score is not intended to be applied to specific populations such as liver failure or HIV subjects and is not accurate when dealing with subjects transferred from another unit or another hospital.

    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-326
    The APACHE II total score must be recalibrated before it can be used in a population other than the general ICU population.
    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-327
     ICU prediction scores in general need to be periodically recalibrated to reflect changes and improvements in practice and subject demographics. Be sure to discuss the use of this instrument with the appropriate regulatory authorities.

    2     Rules and References

    The primary source used in the development of this supplement is Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system [1].

    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-328

    ...

    This document is a supplement to the ADaMIG and is covered under Appendix C of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix C of the ADaMIG for a complete version of this material.

    CDISC does not endorse any QRS instrument and does not specify how to conduct clinical assessments, protocols, or analyses. CDISC disclaims any liability for your use of this material.

    Include this line only for supplements that the US FDA will be reviewing: Although the United States Food and Drug Administration (US FDA) has provided input with regard to this supplement, this input does not constitute US FDA endorsement of any particular instrument.  

    1.2   Copyright Status

    CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the APACHE II in the CDISC library of QRS data standards supplementsThere may be many versions of this instrument in the public domain or copyrighted. CDISC has chosen to use the version attached to the QRS supplement to the SDTMIG, and the QRS supplement to the ADaMIG is based on the same version.

    Note: CDISC Controlled Terminology is maintained by National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS). The most recent versions of the SDTM and ADaM controlled terminologies should be accessed through the CDISC website (https://www.cdisc.org/standards/terminology).

    1.3   Known Issues

    The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity of disease measurement and mortality estimation tool for adult patients applied within 24 hours of admission to an intensive care unit (ICU). The instrument consists of individual items that are summed up to create a total score. This instrument is generally collected once at Screening/Baseline and used as a predictor of mortality rather than an outcome measure. Individual items on this instrument are summed to create a total score but this total score is generally collected as part of the instrument with no instructions provided for handling missing data. In the majority of cases, where APACHE II is only assessed once and the collected total score used as a baseline covariate, the SDTM RS domain may be sufficient to support the analysis requirements.

    2     Rules and References

    The primary source used in the development of this supplement is Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13(10):818–29. The development of the GDS SHORT FORM is discussed in "Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version"[2] by Drs. Sheikh and Yesavage. Validation and possible interpretations of the GDS SHORT FORM are discussed in "The Short Form of the Geriatric Depression Scale: A Comparison With the 30-Item Form."[3]

    All links are valid and referenced information is current as of the date of this ADaMIG QRS supplement. This supplement does not make recommendations for the handling of missing data or adoption of imputation methods.

    3     Scoring Software

    There is no known publicly available scoring software as of the date of this ADaMIG QRS supplement.

    4     Introduction to the Instrument   

    ...

    The APACHE II, is II is a severity-of-disease classification system that uses a point score based on the initial values of 12 routine physiologic measurements, age, and previous health status. Scores range from 0 to 71 and higher scores correspond to more severe disease and a higher risk of death. The composite score is based on findings represented in other SDTM domains such as Laboratory Test Results (LB) and Vital Signs (VS).

    5     Key Data Checks

    The computed total score consists of integer values ranging from 0 to 71. The classification system consists of 11 physiology measures based on a numeric rating scale ( 0 -4) where 0 reflects to 4,

    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-329
    where 0 reflects values within the normal range and an increase in the numeric rating scale represents an increase in the abnormality of the physiology measure in either the high or low direction. Chronological age is divided into disjoint categories and assigned values of (0, 2, 3, 5, 6). For patients with a history of severe organ system insufficiency or who are immunocompromised, a numeric rating of 2 or 5 is assigned for chronic health points, where 2 is assigned “for elective postoperative patients” and 5 is assigned “for nonoperative or emergency postoperative patients”.

    6     Example

    6.1   Background

    Analyses based on ADaM datasets may vary depending on the sponsor, therapeutic area, and the needs of regulatory authorities in their decision-making processes. This fictional example is provided for illustrative purposes only. The ADaM dataset describing the analysis results from an instrument is based on the protocol and statistical analysis plan (SAP) for the individual study.

    The example dataset described here is intended to support a variety of analyses, ranging from simple univariate summary statistics on both the actual total scores and change in total score from baseline by visit to other types of by-visit and repeated-measure analyses. For that reason, standard ADaM BDS variables such as AVAL (analysis value) and CHG (change from baseline) have been included in the example. In addition, because scores can be classified into categorizations of depression severity, frequency of subjects reporting each category may also be generated.

    In the example presented here, it is assumed that the final GDS SHORT FORM analysis dataset (ADGDSSF) contains all of the original records, plus a record for the computed total score for each patient and assessment timepoint. The date of the assessment—and time of the assessment, if collected—should also be included in the dataset. For traceability, raw item-level responses from the SDTM QS.QSORRES variable, stored separately from the analysis variable AVAL, are included. Derivation type (DTYPE) should be used to clearly indicate those records where missing values or other information has been imputed. If useful for analysis, a summary analysis dataset which includes only the computed total score records may also be created.

    This example is based on Yesavage's short form English scoring,[1] which states that if 5 or fewer instrument items are missing, the values of the missing items are imputed as the average of the non-missing responses. If the imputation procedure results in a total score that is not a whole number (e.g., 4.5, 10.2), the total score should be rounded up to the next whole number (i.e., round up to a more severe level of depression). For example, if 3 of the 15 items are missing and the total score based on the 12 non-missing items is 4, then impute the value of each of the 3 missing items as 4/12 = 1/3, for a total score of 4 + (3 * 1/3) = 4 + 1 = 5 (see the Parameter Value Level List - ADGDSSF [AVAL] table). If more than 5 items on the GDS SHORT FORM are missing, no item-level imputation is performed and a total score is not calculated. 

    6.2   Example Analysis Dataset, Variable and Value-level Metadata

    For Serum Creatinine, the measure is assessed on the same scale but double points are assigned for subjects with acute renal failure. The measure evaluating extent of impaired consciousness is calculated as 15 minus the Glasgow Coma Scale (GCS) Score, so that lower scores indicate mild or no impairment and higher scores represent more severe impairment (possible head and/or central nervous system injury) and range from 0 to 12. Chronological age is divided into age groups which are assigned values of 0, 2, 3, 5, or 6

    Jira
    showSummaryfalse
    serverIssue Tracker (JIRA)
    serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
    keyADQRS-330
    .

    For subjects with a history of severe organ system insufficiency or who are immunocompromised, a numeric rating of 2 or 5 is assigned for chronic health points, where 2 is assigned “for elective postoperative subjects” and 5 is assigned “for nonoperative or emergency postoperative subjects”. For subjects who do not have a history of severe organ system insufficiency or who are not immunocompromised, a NOT DONE record may be retained from the source RS domain with the conditional branching flag (RSCBRFL="Y") populated. Additionally, a sponsor may choose to set AVAL=0 for subjects who do not meet the criteria for assigning chronic health points. This decision must be clearly documented, as the analysis value of 0 is logically derived or implied.

    6     Example

    6.1   Background

    Analyses based on ADaM datasets may vary depending on the sponsor, therapeutic area, and the needs of regulatory authorities in their decision-making processes. This fictional example is provided for illustrative purposes only. The ADaM dataset describing the analysis results from an instrument is based on the protocol and statistical analysis plan (SAP) for the individual study.

    The example dataset described here is intended to support a variety of analyses, ranging from simple univariate summary statistics on the actual total scores to other types of by-visit and repeated-measure analyses. For that reason, standard ADaM BDS variables such as AVAL (analysis value) have been included in the example. In addition, although not illustrated in the example, the APACHE II total score can be divided into categories (e.g., <17, >=17) reflecting disease severity or risk of death, and the frequency of subjects reporting in each category may be generated or used for analysis.

    In the example presented here, it is assumed that the final APACHE II analysis dataset (ADAPCH) contains all of the original records, plus a record for the computed total acute physiology score and a record for the computed total APACHE II for each subject and assessment timepoint. The date of the assessment—and time of the assessment, if collected—should also be included in the dataset. For traceability, raw item-level responses from the SDTM RS.RSORRES variable, stored separately from the analysis variable AVAL, are included. Derivation type (DTYPE) should be used to clearly indicate records where missing values have been imputed using sponsor-defined imputation methods. If useful for analysis, a summary analysis dataset which includes only the computed total score records may also be created.

    6.2   Example Analysis Dataset, Variable and Value-level Metadata

    The ADAPCH Dataset Metadata table shows an example of how the APACHE II may be implemented in ADaM. The dataset metadata is a recommendation for the dataset The ADGDSSF Dataset Metadata table shows an example of how the GDS SHORT FORM may be implemented in ADaM. The dataset metadata is a recommendation for the dataset name, label, structure, and keys. These can be modified for sponsor-specific standards and analyses. 

    (Use the table macros to insert these tables. they reside at the end of the document like an appendix)

    Definexmltable
    Definexmltable
    LevelDataset
    PurposeAnalysis
    NameADGDSSFADAPCH

    Dataset

    Label

    Structure

    Keys

    Class

    ADAPCH

    APACHE II Analysis Dataset

    ADGDSSF

    Geriatric Depression Scale SF Analysis

    1 record per subject per timepoint analysis visit per parameter.

    USUBJID, AVISITN, ADT, PARAMN

    BASIC DATA STRUCTURE

    The ADGDSSF ADAPCH Variable Metadata table contains an example of analysis variable metadata for a subset of possible variables available for the GDS SHORT FORMAPACHE II. Example value-level metadata are found in the Parameter Value Level List - ADGDSSF [AVAL] metadata table. Derivations for AVALCAT1 and AVAL included in the Derivation column were obtained from the scoring instructions  for the GDS SHORT FORM[1] and are described in the Introduction to the Instrument section of this supplement. The ADGDSSF Variable ADAPCH metadata table. The ADAPCH Variable Metadata table does not include all of the possible variables that may be present in the Subject-Level Analysis Dataset (ADSL) and copied to the BDS structure analysis dataset, with the exception of the required STUDYID and USUBJID. For a complete list of available ADSL variables, consult the ADaMIG. Some ADSL variables (e.g., INVNAMREGION1) were included in this example for stratification, and are not required.  Additional Additional covariates or other variables may be added as needed for analysis. There is Common BDS variables such as BASE and CHG have been omitted from the example as the majority analyses of APACHE II do not use these variables. There is no specific ordering of variables recommended in this supplement. The SDTM variables were placed next to the corresponding derived ADaM variables for illustration purposes only. Update the below table according to the current QRS Short_Name instrument

    Definexmltable
    Multipletrue
    ExtraUser Notes
    DatasetADGDSSFADAPCH
    LevelVariable
    PurposeAnalysis

    Variable Name

    Variable Label

    Type

    Controlled Terms

    Source

    Derivation

    User Notes

    STUDYID

    Study Identifier

    Char


    QSRS.STUDYID



    USUBJID

    Unique Subject Identifier

    Char


    QSRS.USUBJID



    SITEIDSite Identifier Char 
    ADSL.SITEID 

    QSSEQRSSEQ

    Sequence Number

    Num


    QSRS.QSSEQRSSEQ


    QSSEQ is RSSEQ is included to provide traceability back to SDTM.
    ASEQAnalysis Sequence NumberNum


    After sorting by key variables, renumber all the records from 1 to n within a subject.Provides a sequence number to derived rows which are not present in QSSEQRSSEQ.

    ITTFL

    Intent-to-Treat Population Flag

    Char

    “Y”, “N”

    ADSL.ITTFL


    Conditional; must include at least 1 population flag.

    TRTP

    Planned Treatment

    Char

    "DRUG A + SOC", "SOC"



    Derivation should be defined by sponsor according to analysis needs.   

    Conditional; should include at least 1 treatment variable (e.g., TRTP, TRTA, TRTSEQP, TRT01P).

    PARAM

    Parameter

    Char

     


    See Parameter Value Level List - ADAPCH table.


    PARAMCDParameter Code Char



    See Parameter Value Level List - ADAPCH table

    GDS02TN, GDS02PN

    QS.QSTEST for responses to individual questions copied from SDTM.

    Set PARAM to "GDS02- Total Score - Analysis" for the derived total score.

    PARAMCDParameter Code Char

    GDS02TC, GDS02PC

    QS.QSTESTCD for responses to individual questions copied from SDTM.

    Set PARAMCD to "GDS02TS" for the derived total score.


    PARAMN

    Parameter Number

    Num



    Number of the item in the order it appears on the form; assign a higher value to the derived total score record.

    PARCAT1

    Parameter Category 1

    Char

    "GDS SHORT FORMAPACHE II"


    Set to QSRS.QSCAT RSCAT for records that come directly from SDTM and "GDS SHORT FORMAPACHE II" for any derived records such as total scores or last observed value (LOV).

    VISIT

    Visit Name

    Char


    QSRS.VISIT


    QSRS.VISIT included for traceability.

    VISITNUM

    Visit Number

    Num


    QSRS.VISITNUM


    QSRS.VISITNUM included for traceability.

    AVISIT

    Analysis Visit

    Char




    AVISIT represents the analysis visit for the record. Refer to the SAP for additional details.

    AVISITN

    Analysis Visit (N)

    Num



    A numeric representation of AVISIT. 

    QSDTCRSDTC

    Date/Time of Finding

    Char


    QSRS.QSDTCRSDTC


    QSRS.QSDTC RSDTC included for traceability.

    ADT

    Analysis Date

    Num



    Date portion of QSRS.QSDTC RSDTC converted to numeric and displayed in a format such as DATE9.

    For derived total score records where PARAMCD =in ("APCH1TPS" GDS02TS ", APCH1TS"), this information will be copied from the individual records that comprise that instrument.


    ADY

    Analysis Relative Day

    Num



    ADT-ADSL.TRTSDT+1 if ADT≥TRTSDT; else, ADT-ADSL.TRTSDT if ADT<TRTSDT.This derivation is for example only.

    QSORRESRSORRES

    Finding in Original Units

    Char


    RS.RSORRES



    RSORRESU

    Original Units

    Char

    Char


    RS.RSORRESU



    RSCBRFL

    Conditionally Branched Item Flag

    Char

    "Y"

    SUPPRS.RSCBRFL


    Represents that this item was "NOT DONE" due to conditional branching. AVAL is not populated on this record for this item due to conditional branching.QS.QSORRES

    AVAL

    Analysis Value

    Num



    See Parameter Value Level List - ADGDSSF ADAPCH table.

    DTYPE

    Derivation Type

    AVALCAT1

    Analysis Value Category 1

    Char

    "Normal”, "Possible Depression", "Likely Depression",

    If AVAL<5, then AVALCAT1="Normal";

    If 5<AVAL<10, then AVALCAT1="Possible Depression";

    If AVAL>10, then AVALCAT1="Likely Depression".

    Source: Yesavage[1] 

    WOC"




    ABLFL

    Baseline Record Flag

    Char

    “Y”


    Set ABLFL="Y" on the record defined as the baseline value. This flag will only be populated on the derived acute physiology and APACHE II total score records (PARAMCD in ("APCH1TPS" "APCH1TS"))

    BASE

    Baseline Value

    Num

    BASE=AVAL where ABLFL="Y".Only the derived total score records where PARAMCD="GDS02TS" should have BASE populated in this example.
    CHGCOUNTRYChange from BaselineCountry

    Num

    CHG=AVAL-BASEOnly populate for post-baseline total score records in this example (where PARAMCD="GDS02TS" and ADY>1).

    DTYPE

    Derivation Type

    Char

    “AVERAGE”, “LOV”

    For PARAMCD="GDS02TS": If the scoring instructions on the GDS SHORT FORM web page are followed and 1-5 responses are missing on the instrument, then populate DTYPE with "AVERAGE". Other missing value imputations for individual questions are indicated with DTYPE="AVERAGE", and imputations for a completely missing total score and a derived endpoint record can be indicated with DTYPE="LOV" in this example.

    Otherwise, leave NULL.

    ABLFL

    Baseline Record Flag

    Char

    “Y”

    Set ABLFL="Y" on the record defined as the baseline value. This flag will only be populated on the derived total score records (PARAMCD="GDS02TS") in this example.

    ANL01FL

    Analysis Record Flag 01

    Char

    “Y”

    Set ANL01FL="Y" on derived total score records (PARAMCD="GDS02TS") associated with scheduled visits in this example (VISIT is not of the form "UNSCHEDULED XXX.XX"). Permissible and useful for selecting records that are used in SAP-specified analyses.

    INVNAM

    Investigator Name

    Char

    ADSL.INVNAM

    Permissible if needed for analysis.

    The following SDTM variables can be copied into the corresponding equivalent ADaM variables. Note that the SDTM variable values can be converted to mixed case as needed for analysis purposes.  The Action column shown in the table below is optional, and can be removed if all values for these variables are simply copied over from SDTM.  For supplements where the SDTM values are modified, please provide a description of what was done.  For example, in the CHART-SF supplement, PARAM/PARAMCD are modified by replacing the version number with 'A', so that action is described here as "Harmonizing the two methods of administration (Paper and Interview) for individual items.  Fragment representing version number is changed to an 'A'."

    ...

    SDTM Variable

    ...

    ADaM Variable

    ...

    QSTESTCD

    ...

    PARAMCD

    ...

    QSTEST

    ...

    PARAM

    ...

    QSCAT

    ...

    PARCAT1

    ...

    QSSTRESN

    ...

    AVAL

    ...

    All controlled terminology for instruments in both SDTM and ADaM is associated with a specific version of the instrument. When integrating responses from an instrument across studies, it is important to know which version of the instrument was used for each study. When multiple versions of the same instrument exist in an integration, a pooled analysis of responses across different versions can only be performed if determined to be clinically and statistically acceptable. In that case, sponsor-defined terminology, similar to CDISC Controlled Terminology but without the reference to a specific version, should be used for PARAMCD, PARAM and PARCATy.

    ...

    ExtraUser Notes
    DatasetADGDSSF
    LevelValue
    PurposeAnalysis
    NameAVAL
    Char
    ADSL.COUNTRY

    Permissible if needed for analysis. Generally represented using ISO 3166-1 Alpha-3. Note that regulatory agency specific requirements (e.g., US FDA) may require other terminologies; in such cases, follow regulatory requirements.    

    REGION1

    Geographic Region 1

    Char


    ADSL.REGION1


    Permissible if needed for analysis.

    REGION1N

    Geographic Region 1 (N)

    Num


    ADSL.REGION1N


    Permissible if needed for analysis.

    The following SDTM variables can be copied into the corresponding equivalent ADaM variables. Note that the SDTM variable values can be converted to mixed case as needed for analysis purposes.  

    Metadataspec

    SDTM Variable

    ADaM Variable

    RSTESTCD

    PARAMCD

    RSTEST

    PARAM

    RSCAT

    PARCAT1

    RSSTRESN

    AVAL

    All controlled terminology for instruments in both SDTM and ADaM is associated with a specific version of the instrument. When integrating responses from an instrument across studies, it is important to know which version of the instrument was used for each study. When multiple versions of the same instrument exist in an integration, a pooled analysis of responses across different versions can only be performed if determined to be clinically and statistically acceptable. In that case, sponsor-defined terminology, similar to CDISC Controlled Terminology but without the reference to a specific version, should be used for PARAMCD, PARAM and PARCATy.

    Definexmltable
    ExtraUser Notes
    DatasetADAPCH
    LevelValue
    PurposeAnalysis
    NameAVAL

    Variable

    Where

    Type

    Controlled Terms

    Source

    Derivation

    User Notes

    AVAL

    PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis))

    Num



    Set AVAL=RS.RSSTRESN.The analysis value is the result copied from SDTM.

    AVAL

    PARAMCD EQ "APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis)

    Num



    The sum of RS.RSSTRESN for RS.RSTESTCD in ("APCH101"-"APCH112") if no items are missing. Note that among item pairs RSTESTCD in ("APCH105A", "APCH105B") as well as RSTESTCD in ("APCH106A", "APCH106B") only one item is expected to be answered and not both, respectively.

    The expectation is that issues pertaining to conditional branching (e.g., both items answered) are queried and fixed in SDTM RS. If this is not possible, the statistician will provide guidance and documentation of how to conduct the analysis given the circumstance (e.g. worst score).

    AVAL

    PARAMCD EQ "APCH1TS" (APCH1-Total APACHE II Score - Analysis)

    Num



    The sum of RS.RSSTRESN for RS.RSTESTCD in ("APCH101"-"APCH112") and "APCH114", "APCH115" if no items are missing. Note that among item pairs RSTESTCD in ("APCH105A", "APCH105B") as well as RSTESTCD in ("APCH106A", "APCH106B") only one item is expected to be answered and not both, respectively.

    If a subject dies on or before Day 15, they are assigned the highest observed APACHE II score of any of the subjects at any time during the trial for their Total APACHE II Score at Day 15 (Day of Discharge).

    The assignment of the highest observed APACHE II score is for illustration purposes only and not meant as a recommendation.

    PARAMCD

    PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis))

    Char

    APCH1TC


    See CDISC Controlled Terminology for Clinical Classification Test Codes. RS.RSTESTCD for responses to individual items copied from SDTM.


    PARAMCD

    PARAMCD IN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis))

    Char

    APCH1PC


    See CDISC Controlled Terminology for Parameter Codes.


    PARAM

    PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis))

    Char

    APCH1TN


    See CDISC Controlled Terminology for Clinical Classification Test Names. RS.RSTEST for responses to individual items copied from SDTM.


    PARAM

    PARAMCD IN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis))

    Char

    APCH1PN


    See CDISC Controlled Terminology for Parameter Names.


    6.3   Example Analysis Dataset 

    The APACHE II Analysis Dataset tables below show the terminology and variables for implementing the example analysis dataset for this instrument in the BDS. This specific example is taken from a Phase II, randomized, controlled, open label multi-center study to assess the efficacy and safety of Drug A for the treatment of SARS-CoV-2 infected subjects with COVID-19 pneumonia and impaired respiratory function. The primary outcome measure is APACHE II Severity of Disease Score on Day 15 or on the Day of Discharge (whichever is earlier). This measure compares "Drug A + SOC" with "SOC" (SOC = Standard of Care). 

    In this example, the APACHE II was measured within 24 hours of ICU admission, on or before Day 1 (prior to implementation of treatment), Day 7, and Day 15 or on the day of discharge (whichever was earlier). In the example, as per the SAP, subjects who died on Day 15 or earlier were assigned the highest observed APACHE II score of any of the subjects at any time during the trial (worst case imputation for deaths). This imputation method is for example purposes only and not meant to be a recommendation nor considered a common practice. Missing data values for the parameters required for the derivation of the APACHE II score were replaced by the last available assessment. Item level imputation, in this example, is handled by the investigators and/or clinicians at the site and is considered source data, already captured in SDTM. SOC included a variety of supportive therapies that ranged from the administration of supplementary oxygen to full intensive care support, alongside the use of antiviral treatment, convalescent plasma, corticosteroids, antibiotics or other agents.

    In the example, the

    ...

    Variable

    ...

    Where

    ...

    Type

    ...

    Controlled Terms

    ...

    Source

    ...

    Derivation

    ...

    User Notes

    ...

    AVAL

    ...

    PARAMCD NE "GDS02TS" (GDS02- Total Score - Analysis)

    ...

    Num

    ...

    AVAL

    ...

    PARAMCD EQ "GDS02TS" (GDS02- Total Score - Analysis)

    ...

    Num

    ...

    The sum of QS.QSSTRESN for QS.QSTESTCD in ("GDS0201"-"GDS0215") if no question are missing.

    • If ≤5 responses are missing on an instrument, then AVAL is 15*(sum of non-missing QS.QSSTRESN for QS.QSTESTCD in ("GDS0201"-"GDS0215")/number of non-missing questions for QS.QSTESTCD in ("GDS0201"-"GDS0215"). If the result is a fraction, round up to the nearest integer.
    • If >5 responses are missing, do not calculate a total score, and do not create a total score record.

    6.3   Example Analysis Dataset 

    The GDS SHORT FORM Summary Analysis Dataset table shows the terminology and variables for implementing the example analysis dataset for this instrument in the BDS. This specific example is taken from a multicenter, randomized, double-blind, active-controlled parallel design study conducted in elderly patients with major depressive disorder. The purpose of the analysis is to compare the effect of Drug A to Drug B on depression in elderly patients using the GDS SHORT FORM to construct an endpoint. All analyses are conducted on an intent-to-treat basis, and the planned duration of treatment is 5 months. The baseline measurement is defined as the last non-missing value collected at or prior to the start of treatment; change from the last non-missing post-baseline value to baseline is used to construct an endpoint. The SAP specifies that planned collected visits, including baseline measurements, are to be used in analyses and displays of results. In fact, whereas no unscheduled visits appear only in listings. The total score records for 1 subject were collected at 3 visits, plus a derived last observed value (LOV) endpoint record for the GDS SHORT FORM. Visit 1 is remapped to AVISIT = "BASELINE". There are 2 visits at AVISIT = "VISIT 2". However, because 1 visit was unscheduled, it is not used in the analysis and the ANL01FL value is null. Visits 5 and 6 are missing because the subject discontinued early due to an adverse event unrelated to treatment.

    Update the below dataset and title according to the current QRS Short_Name instrument.  

    GDS SHORT FORM Complete Analysis Dataset

    exist in the source data. If the planned physiology assessment is not done or invalid, the investigator may choose to use a previous or repeat assessment of that parameter as the value at that visit for the scoring of APACHE II. The records for 2 subjects are shown in the example datasets. The data for 3 visits is shown for the first subject, with no missing data. The data for 1 visit is shown for the second subject, who died before the Day 15 (Day of Discharge) Visit so the APACHE II total score is imputed to the worst case value of any subjects across any timepoints at that visit. Note that the worst case value is not shown in the sample data.

    APACHE II Complete Analysis Dataset

    The APACHE II Complete Analysis Dataset table shows all of the individual item The GDS SHORT FORM Complete Analysis Dataset table shows all of the individual question responses for this example, as well as the computed total Acute Physiology score and the computed total APACHE II score. This example is considered to be the final analysis dataset for submission. Computed total scores can appear after the individual item responses, with appropriate labels for identification.

    Dataset wrap
    Nameadgdssfadapch
    CHG
    Dataset2
    RowSTUDYIDUSUBJIDSITEID
    QSSEQ
    RSSEQASEQITTFLTRTPPARAMPARAMCDPARAMNPARCAT1VISITVISITNUMAVISITAVISITN
    QSDTC
    RSDTCADTADY
    QSORRES
    RSORRES
    AVAL
    RSORRESU
    AVALCAT1
    RSCBRFL

    BASE

    AVALDTYPEABLFLCOUNTRY
    ANL01FL
    REGION1
    INVNAM
    REGION1N
    1STUDYXX-
    101
    100-P0001
    101
    10011YDRUG A + SOC

    GDS02-Satisfied With Life

    APCH1-Temperature - RectalAPCH101
    GDS0201
    1

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0

    2012-11-16

    2020-06-2929JUN2020138.5-38.9C
    16NOV2012

    1
    YES


    USA

    0

    DR. JOHN SMITH
    North America1
    2STUDYXX-
    101
    100-P0001
    101
    10022YDRUG A + SOC

    GDS02-Dropped Activities and Interests

    APCH1-Mean Arterial PressureAPCH102
    GDS0202
    2

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    110-129mmHg
    2

    USANorth America
    YES
    1

    DR. JOHN SMITH

    3STUDYXX-
    101
    100-P0001
    101
    10033YDRUG A + SOC

    GDS02-Life Is Empty

    APCH1-Heart RateAPCH103
    GDS0203
    3

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201

    NO

    0

    70-109beats/min
    0

    USANorth America1
    DR. JOHN SMITH
    4STUDYXX-
    101
    100-P0001
    101
    10044YDRUG A + SOC
    GDS02
    APCH1-
    Bored Often
    Respiratory Rate
    GDS0204
    APCH1044

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    YES
    25-34breaths/min
    1
    DR. JOHN SMITH


    USANorth America1
    5STUDYXX-
    101
    100-P0001
    101
    10055YDRUG A

    GDS02-Good Spirits Most of Time

    + SOCAPCH1-Oxygenation: A-aDO2APCH105A
    GDS0205
    5

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    NO


    Y


    USANorth America1

    DR. JOHN SMITH

    6STUDYXX-
    101
    100-P0001
    101
    10066YDRUG A + SOC

    GDS02-Afraid of Something Bad Happening

    APCH1-Oxygenation: PaO2APCH105B
    GDS0206
    6

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    YES
    61-70mmHg
    1
    DR. JOHN SMITH


    USANorth America1
    7STUDYXX-
    101
    100-P0001
    101
    10077YDRUG A + SOC

    GDS02-Feel Happy Most of Time

    APCH1-Arterial pHAPCH106A
    GDS0207
    7

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0

    2012-11-16

    16NOV2012

    1

    NO

    1

    DR. JOHN SMITH

    2020-06-2929JUN202017.15-7.24

    3

    USANorth America1
    8STUDYXX-
    101
    100-P0001
    101
    10088YDRUG A + SOC

    GDS02-Often Feel Helpless

    APCH1-Serum HCO3APCH106B
    GDS0208
    8

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    YES


    Y


    USANorth America1
    DR. JOHN SMITH
    9STUDYXX-
    101
    100-P0001
    101
    10099YDRUG A + SOC

    GDS02-Prefer to Stay Home

    APCH1-Serum SodiumAPCH107
    GDS0209
    9

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0

    2012-11-16

    2020-06-2929JUN20201150-154mmol/L
    16NOV2012

    1
    NO


    USA

    0

    North America1
    DR. JOHN SMITH
    10STUDYXX-
    101
    100-P0001
    101
    1001010YDRUG A + SOC
    GDS02
    APCH1-
    Memory Problems
    Serum Potassium
    GDS0210
    APCH10810

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    3.5-5.4mmol/L
    0

    USANorth America
    YES
    1

    DR. JOHN SMITH

    11STUDYXX-
    101
    100-P0001
    101
    1001111YDRUG A + SOC

    GDS02-Wonderful to Be Alive

    APCH1-Serum CreatinineAPCH109
    GDS0211
    11

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0

    2012-11-16

    16NOV2012

    1

    NO

    1

    2020-06-2929JUN20201<0.6mg/dL
    2

    USANorth America1
    DR. JOHN SMITH
    12STUDYXX-
    101
    100-P0001
    101
    1001212YDRUG A + SOC
    GDS02
    APCH1-
    Feel Worthless
    Hematocrit
    GDS0212
    APCH11012

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201

    YES

    1

    DR. JOHN SMITH
    20-29.9%
    2

    USANorth America1
    13STUDYXX-
    101
    100-P0001
    101
    1001313YDRUG A + SOC

    GDS02-Feel Full of Energy

    APCH1-White Blood CountAPCH111
    GDS0213
    13

    GDS SHORT FORM

    APACHE IISCREENING1Baseline02020-06-2929JUN2020
    VISIT 1
    1

    BASELINE

    0

    2012-11-16

    16NOV2012

    1

    YES

    0

    20-39.910^9/L
    2

    USANorth America1
    DR. JOHN SMITH
    14STUDYXX-
    101
    100-P0001
    101
    1001414YDRUG A + SOC

    GDS02-Feel Hopeless

    APCH1-15 Minus Glasgow Coma ScoreAPCH112
    GDS0214
    14

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    3

    3

    USANorth America
    YES
    1

    DR. JOHN SMITH

    15STUDYXX-
    101
    100-P0001
    101
    1001515YDRUG A + SOC

    GDS02-Most People Better Off Than You

    APCH1-A: Total Acute Physiology ScoreAPCH113
    GDS0215
    15

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN2020118

    18
    NO


    USA

    0

    North America1
    DR. JOHN SMITH
    16STUDYXX-
    101
    100-P0001
    101
    100
    16YDRUG A + SOC
    GDS02
    APCH1-A: Total Acute Physiology Score - Analysis
    GDS02TS
    APCH1TPS16

    GDS SHORT FORM

    APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0
    2012
    2020-
    11
    06-
    16
    29
    16NOV2012
    29JUN20201
    10



    18
    Possible Depression

    Y
    10
    USA
    Y
    North America
    Y
    1

    DR. JOHN SMITH

    17STUDYXX-
    101
    100-P0001
    101
    1001617YDRUG A + SOC

    GDS02-Satisfied With Life

    APCH1-B: Age PointsAPCH11417APACHE IISCREENING
    GDS0201
    1

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    0

    Baseline02020-06-2929JUN2020145-54YEARS
    2

    USANorth America1
    DR. JOHN SMITH
    18STUDYXX-
    101
    100-P0001
    101
    1001718YDRUG A + SOC

    GDS02-Dropped Activities and Interests

    GDS0202

    2

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    0

    APCH1-C: Chronic Health PointsAPCH11518APACHE IISCREENING1Baseline02020-06-2929JUN20201for elective postoperative patients

    2

    USANorth America1
    DR. JOHN SMITH
    19STUDYXX-
    101
    100-P0001
    101
    1001819YDRUG A + SOC

    GDS02-Life Is Empty

    GDS0203

    3

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    0

    APCH1-Total APACHE II ScoreAPCH11619APACHE IISCREENING1Baseline02020-06-2929JUN2020122

    22

    USANorth America1
    DR. JOHN SMITH
    20STUDYXX-
    101
    100-P0001
    101
    100

    19


    20YDRUG A

    GDS02-Bored Often

    GDS0204

    4

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    1

    DR. JOHN SMITH

    + SOCAPCH1-Total APACHE II Score - AnalysisAPCH1TS20APACHE IISCREENING1Baseline02020-06-2929JUN20201


    22
    YUSANorth America1
    21STUDYXX-
    101
    100-P0001
    101
    100
    20
    1921YDRUG A + SOC

    GDS02-Good Spirits Most of Time

    GDS0205

    5

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    1

    APCH1-Temperature - RectalAPCH1011APACHE IIDAY 77Day 772020-07-0505JUL2020738.5-38.9C
    1

    USANorth America1
    DR. JOHN SMITH
    22STUDYXX-
    101
    100-P0001
    101
    100
    21
    2022YDRUG A + SOC

    GDS02-Afraid of Something Bad Happening

    GDS0206

    6

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    1

    DR. JOHN SMITH

    APCH1-Mean Arterial PressureAPCH1022APACHE IIDAY 77Day 772020-07-0505JUL2020770–109mmHg
    0

    USANorth America1
    23STUDYXX-
    101
    100-P0001
    101
    100
    22
    2123YDRUG A + SOC

    GDS02-Feel Happy Most of Time

    GDS0207

    7

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    1

    APCH1-Heart RateAPCH1033APACHE IIDAY 77Day 772020-07-0505JUL2020770-109beats/min
    0

    USANorth America1
    DR. JOHN SMITH
    24STUDYXX-
    101
    100-P0001
    101
    100
    23
    2224YDRUG A + SOC

    GDS02-Often Feel Helpless

    GDS0208

    8

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    1

    APCH1-Respiratory RateAPCH1044APACHE IIDAY 77Day 772020-07-0505JUL2020725-34breaths/min
    1

    USANorth America1
    DR. JOHN SMITH
    25STUDYXX-
    101
    100-P0001
    101
    100
    24
    2325YDRUG A

    GDS02-Prefer to Stay Home

    GDS0209

    9

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    0

    + SOCAPCH1-Oxygenation: A-aDO2APCH105A5APACHE IIDAY 77Day 772020-07-0505JUL20207

    Y


    USANorth America1
    DR. JOHN SMITH
    26STUDYXX-
    101
    100-P0001
    101
    100
    25
    2426YDRUG A + SOC

    GDS02-Memory Problems

    GDS0210

    10

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    0

    APCH1-Oxygenation: PaO2APCH105B6APACHE IIDAY 77Day 772020-07-0505JUL2020761-70mmHg
    1

    USANorth America1
    DR. JOHN SMITH
    27STUDYXX-
    101
    100-P0001
    101
    100
    26
    2527YDRUG A + SOC

    GDS02-Wonderful to Be Alive

    GDS0211

    11

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    1

    DR. JOHN SMITH

    APCH1-Arterial pHAPCH106A7APACHE IIDAY 77Day 772020-07-0505JUL202077.25-7.32

    2

    USANorth America1
    28STUDYXX-
    101
    100-P0001
    101
    100
    27
    2628YDRUG A + SOC
    GDS02
    APCH1-
    Feel Worthless
    Serum HCO3
    GDS0212
    APCH106B

    12

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    1

    DR. JOHN SMITH
    8APACHE IIDAY 77Day 772020-07-0505JUL20207

    Y


    USANorth America1
    29STUDYXX-
    101
    100-P0001
    101
    100
    28
    2729YDRUG A + SOC

    GDS02-Feel Full of Energy

    GDS0213

    13

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    0

    APCH1-Serum SodiumAPCH1079APACHE IIDAY 77Day 772020-07-0505JUL20207150-154mmol/L
    1

    USANorth America1
    DR. JOHN SMITH
    30STUDYXX-
    101
    100-P0001
    101
    100
    29
    2830YDRUG A + SOC

    GDS02-Feel Hopeless

    GDS0214

    14

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    YES

    1

    DR. JOHN SMITH

    APCH1-Serum PotassiumAPCH10810APACHE IIDAY 77Day 772020-07-0505JUL202073.5-5.4mmol/L
    0

    USANorth America1
    31STUDYXX-
    101
    100-P0001
    101
    100
    30
    2931YDRUG A + SOC

    GDS02-Most People Better Off Than You

    GDS0215

    15

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    NO

    0

    APCH1-Serum CreatinineAPCH10911APACHE IIDAY 77Day 772020-07-0505JUL202070.6-1.4mg/dL
    0

    USANorth America1
    DR. JOHN SMITH
    32STUDYXX-
    101
    100-P0001100
    101
    3032YDRUG A + SOC

    GDS02- Total Score - Analysis

    GDS02TS

    16

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    2012-12-15

    15DEC2012

    30

    8

    Possible Depression

    10

    -2

    Y

    DR. JOHN SMITH
    APCH1-HematocritAPCH11012APACHE IIDAY 77Day 772020-07-0505JUL2020720-29.9%
    2

    USANorth America1
    33STUDYXX-
    101
    100-P0001
    101
    1003133YDRUG A + SOC

    GDS02-Satisfied With Life

    GDS0201

    1

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    0

    APCH1-White Blood CountAPCH11113APACHE IIDAY 77Day 772020-07-0505JUL2020715-19.910^9/L
    1

    USANorth America1
    DR. JOHN SMITH
    34STUDYXX-
    101
    100-P0001
    101
    1003234YDRUG A + SOC

    GDS02-Dropped Activities and Interests

    GDS0202

    2

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    0

    APCH1-15 Minus Glasgow Coma ScoreAPCH11214APACHE IIDAY 77Day 772020-07-0505JUL202071

    1

    USANorth America1
    DR. JOHN SMITH
    35STUDYXX-
    101
    100-P0001
    101
    1003335YDRUG A + SOC

    GDS02-Life Is Empty

    GDS0203

    3

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    APCH1-A: Total Acute Physiology ScoreAPCH11315APACHE IIDAY 77Day 772020-07-0505JUL2020710

    10

    USANorth America1
    DR. JOHN SMITH
    36STUDYXX-
    101
    100-P0001
    101
    100

    34


    36YDRUG A

    GDS02-Bored Often

    GDS0204

    4

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    + SOCAPCH1-A: Total Acute Physiology Score - AnalysisAPCH1TPS16APACHE IIDAY 77Day 772020-07-0505JUL20207


    10

    USANorth America1
    DR. JOHN SMITH
    37STUDYXX-
    101
    100-P0001
    101
    100
    35
    3437YDRUG A + SOC

    GDS02-Good Spirits Most of Time

    GDS0205

    5

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    1

    APCH1-B: Age PointsAPCH11417APACHE IIDAY 77Day 772020-07-0505JUL2020745-54YEARS
    2

    USANorth America1
    DR. JOHN SMITH
    38STUDYXX-
    101
    100-P0001
    101
    100
    36
    3538YDRUG A + SOC

    GDS02-Afraid of Something Bad Happening

    GDS0206

    6

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    DR. JOHN SMITH

    APCH1-C: Chronic Health PointsAPCH11518APACHE IIDAY 77Day 772020-07-0505JUL20207for elective postoperative patients

    2

    USANorth America1
    39STUDYXX-
    101
    100-P0001
    101
    100
    37
    3639Y

    DRUG A

    GDS02-Feel Happy Most of Time

    GDS0207

    7

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    0

    DRUG A + SOCAPCH1-Total APACHE II ScoreAPCH11619APACHE IIDAY 77Day 772020-07-0505JUL2020714

    14

    USANorth America1
    DR. JOHN SMITH
    40STUDYXX-
    10138
    100-P0001

    101

    100
    40YDRUG A

    GDS02-Often Feel Helpless

    GDS0208

    8

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    DR. JOHN SMITH

    + SOCAPCH1-Total APACHE II Score - AnalysisAPCH1TS20APACHE IIDAY 77Day 772020-07-0505JUL20207


    14

    USANorth America1
    41STUDYXX-
    101
    100-P0001
    101
    100
    39
    3741YDRUG A + SOC

    GDS02-Prefer to Stay Home

    GDS0209

    9

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    0

    APCH1-Temperature - RectalAPCH1011APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201536-38.4C
    0

    USANorth America1
    DR. JOHN SMITH
    42STUDYXX-
    101
    100-P0001
    101
    100
    40
    3842YDRUG A + SOC

    GDS02-Memory Problems

    GDS0210

    10

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    0

    APCH1-Mean Arterial PressureAPCH1022APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201570–109mmHg
    0

    USANorth America1
    DR. JOHN SMITH
    43STUDYXX-
    101
    100-P0001
    101
    100
    41
    3943YDRUG A + SOC

    GDS02-Wonderful to Be Alive

    GDS0211

    11

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    1

    DR. JOHN SMITH

    APCH1-Heart RateAPCH1033APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201570-109beats/min
    0

    USANorth America1
    44STUDYXX-
    101
    100-P0001
    101
    100
    42
    4044YDRUG A + SOC
    GDS02
    APCH1-
    Feel Worthless
    Respiratory Rate
    GDS0212
    APCH104

    12

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    4APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201512–24breaths/min
    0

    USANorth America1
    DR. JOHN SMITH
    45STUDYXX-
    101
    100-P0001
    101
    100
    43
    4145YDRUG A

    GDS02-Feel Full of Energy

    GDS0213

    13

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    0

    + SOCAPCH1-Oxygenation: A-aDO2APCH105A5APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015

    Y


    USANorth America1
    DR. JOHN SMITH
    46STUDYXX-
    101
    100-P0001
    101
    100
    44
    4246YDRUG A + SOC

    GDS02-Feel Hopeless

    GDS0214

    14

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    YES

    1

    APCH1-Oxygenation: PaO2APCH105B6APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201561-70mmHg
    1

    USANorth America1
    DR. JOHN SMITH
    47STUDYXX-
    101
    100-P0001
    101
    100
    45
    4347YDRUG A + SOC

    GDS02-Most People Better Off Than You

    GDS0215

    15

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    NO

    0

    APCH1-Arterial pHAPCH106A7APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020157.33-7.49

    0

    USANorth America1
    DR. JOHN SMITH
    48STUDYXX-
    101
    100-P0001
    101
    100
    46
    4448YDRUG A + SOC

    GDS02- Total Score - Analysis

    GDS02TS

    16

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    UNSCHEDULED 2.01

    2

    2012-12-28

    28DEC2012

    43

    9

    Possible Depression

    10

    -1

    DR. JOHN SMITH
    APCH1-Serum HCO3APCH106B8APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015

    Y


    USANorth America1
    49STUDYXX-
    101
    100-P0001
    101
    1004549YDRUG A + SOC

    GDS02-Satisfied With Life

    GDS0201

    1

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    0.46

    AVERAGE

    APCH1-Serum SodiumAPCH1079APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015130-149mmol/L
    0

    USANorth America1
    DR. JOHN SMITH
    50STUDYXX-
    101
    100-P0001100
    101
    4650YDRUG A + SOC

    GDS02-Dropped Activities and Interests

    GDS0202

    2

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    0.46

    AVERAGE

    APCH1-Serum PotassiumAPCH10810APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020153.5-5.4mmol/L
    0

    USANorth America1
    DR. JOHN SMITH
    51STUDYXX-
    101
    100-P0001
    101
    1004751YDRUG A + SOC

    GDS02-Life Is Empty

    GDS0203

    3

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    0

    APCH1-Serum CreatinineAPCH10911APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020150.6-1.4mg/dL
    0

    USANorth America1
    DR. JOHN SMITH
    52STUDYXX-
    101
    100-P0001
    101
    1004852YDRUG A + SOC
    GDS02
    APCH1-
    Bored Often
    Hematocrit
    GDS0204
    APCH110

    4

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    0

    12APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201546-49.9%
    1

    USANorth America1
    DR. JOHN SMITH
    53STUDYXX-
    101
    100-P0001
    101
    1004953YDRUG A + SOC

    GDS02-Good Spirits Most of Time

    GDS0205

    5

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    0

    APCH1-White Blood CountAPCH11113APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020153-14.910^9/L
    0

    USANorth America1
    DR. JOHN SMITH
    54STUDYXX-
    101
    100-P0001
    101
    1005054YDRUG A + SOC

    GDS02-Afraid of Something Bad Happening

    GDS0206

    6

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    1

    DR. JOHN SMITH

    APCH1-15 Minus Glasgow Coma ScoreAPCH11214APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020150

    0

    USANorth America1
    55STUDYXX-
    101
    100-P0001
    101
    1005155YDRUG A + SOC

    GDS02-Feel Happy Most of Time

    GDS0207

    7

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    1

    DR. JOHN SMITH

    APCH1-A: Total Acute Physiology ScoreAPCH11315APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020152

    2

    USANorth America1
    56STUDYXX-
    10152
    100-P0001

    101

    100
    56YDRUG A

    GDS02-Often Feel Helpless

    GDS0208

    8

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    1

    + SOCAPCH1-A: Total Acute Physiology Score - AnalysisAPCH1TPS16APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015


    2

    USANorth America1
    DR. JOHN SMITH
    57STUDYXX-
    101
    100-P0001
    101
    100
    53
    5257YDRUG A + SOC

    GDS02-Prefer to Stay Home

    GDS0209

    9

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    0

    APCH1-B: Age PointsAPCH11417APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL20201545-54YEARS
    2

    USANorth America1
    DR. JOHN SMITH
    58STUDYXX-
    101
    100-P0001
    101
    100
    54
    5358YDRUG A + SOC

    GDS02-Memory Problems

    GDS0210

    10

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    0

    APCH1-C: Chronic Health PointsAPCH11518APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015for elective postoperative patients

    2

    USANorth America1
    DR. JOHN SMITH
    59STUDYXX-
    101
    100-P0001
    101
    100
    55
    5459YDRUG A + SOC

    GDS02-Wonderful to Be Alive

    GDS0211

    11

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    1

    DR. JOHN SMITH

    APCH1-Total APACHE II ScoreAPCH11619APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL2020156

    6

    USANorth America1
    60STUDYXX-
    10156
    100-P0001

    101

    100
    60YDRUG A

    GDS02-Feel Worthless

    GDS0212

    12

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    1

    DR. JOHN SMITH

    + SOCAPCH1-Total APACHE II Score - AnalysisAPCH1TS20APACHE IIDAY 1515Day 15 (Day of Discharge)152020-07-1313JUL202015


    6

    USANorth America1
    61STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    57
    1
    61
    1Y

    DRUG A

    GDS02-Feel Full of Energy

    GDS0213

    13

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    0

    DR. JOHN SMITH

    SOCAPCH1-Temperature - RectalAPCH1011APACHE IISCREENING1Baseline02020-08-0404AUG2020-138.5-38.9C
    1

    GBRNon-North America0
    62STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    58
    2
    62
    2Y
    DRUG A
    SOC

    GDS02-Feel Hopeless

    GDS0214

    14

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    YES

    1

    APCH1-Mean Arterial PressureAPCH1022APACHE IISCREENING1Baseline02020-08-0404AUG2020-1110-129mmHg
    2

    GBRNon-North America0
    DR. JOHN SMITH
    63STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    59
    3
    63
    3Y
    DRUG A
    SOC

    GDS02-Most People Better Off Than You

    GDS0215

    15

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    NO

    0

    APCH1-Heart RateAPCH1033APACHE IISCREENING1Baseline02020-08-0404AUG2020-170-109beats/min
    0

    GBRNon-North America0
    DR. JOHN SMITH
    64STUDYXX-
    101
    200-
    P0001
    P0002200
    101
    4
    64
    4Y
    DRUG A
    SOC

    GDS02- Total Score - Analysis

    GDS02TS

    16

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    2013-01-12

    12JAN2013

    58

    7

    Possible Depression

    10

    -3

    AVERAGE

    Y

    DR. JOHN SMITH

    APCH1-Respiratory RateAPCH1044APACHE IISCREENING1Baseline02020-08-0404AUG2020-1>=50breaths/min
    4

    GBRNon-North America0
    65STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    60
    5
    65
    5Y

    DRUG A

    GDS02-Satisfied With Life

    GDS0201

    1

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    YES

    0

    DR. JOHN SMITH

    SOCAPCH1-Oxygenation: A-aDO2APCH105A5APACHE IISCREENING1Baseline02020-08-0404AUG2020-1

    Y


    GBRNon-North America0
    66STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    61
    6
    66
    6Y
    DRUG A
    SOC

    GDS02-Dropped Activities and Interests

    GDS0202

    2

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    APCH1-Oxygenation: PaO2APCH105B6APACHE IISCREENING1Baseline02020-08-0404AUG2020-161-70mmHg
    1

    GBRNon-North America0
    DR. JOHN SMITH
    67STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    62
    7
    67
    7Y
    DRUG A
    SOC

    GDS02-Life Is Empty

    GDS0203

    3

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-Arterial pHAPCH106A7APACHE IISCREENING1Baseline02020-08-0404AUG2020-1<7.15

    4

    GBRNon-North America0
    68STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    63
    8
    68
    8Y
    DRUG A
    SOC
    GDS02
    APCH1-
    Bored Often
    Serum HCO3
    GDS0204
    APCH106B

    4

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    8APACHE IISCREENING1Baseline02020-08-0404AUG2020-1

    Y


    GBRNon-North America0
    69STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    64
    9
    69
    9Y
    DRUG A
    SOC

    GDS02-Good Spirits Most of Time

    GDS0205

    5

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    YES

    0

    APCH1-Serum SodiumAPCH1079APACHE IISCREENING1Baseline02020-08-0404AUG2020-1150-154mmol/L
    1

    GBRNon-North America0
    DR. JOHN SMITH
    70STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    65
    10
    70
    10Y
    DRUG A
    SOC

    GDS02-Afraid of Something Bad Happening

    GDS0206

    6

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    YES

    1

    APCH1-Serum PotassiumAPCH10810APACHE IISCREENING1Baseline02020-08-0404AUG2020-13.5-5.4mmol/L
    0

    GBRNon-North America0
    DR. JOHN SMITH
    71STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    66
    11
    71
    11Y
    DRUG A
    SOC

    GDS02-Feel Happy Most of Time

    GDS0207

    7

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    1

    APCH1-Serum CreatinineAPCH10911APACHE IISCREENING1Baseline02020-08-0404AUG2020-1<0.6mg/dL
    2

    GBRNon-North America0
    DR. JOHN SMITH
    72STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    67
    12
    72
    12Y

    DRUG A

    GDS02-Often Feel Helpless

    GDS0208

    8

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    SOCAPCH1-HematocritAPCH11012APACHE IISCREENING1Baseline02020-08-0404AUG2020-120-29.9%
    2

    GBRNon-North America0
    73STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    68
    13
    73
    13Y
    DRUG A
    SOC

    GDS02-Prefer to Stay Home

    GDS0209

    9

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-White Blood CountAPCH11113APACHE IISCREENING1Baseline02020-08-0404AUG2020-1>=4010^9/L
    4

    GBRNon-North America0
    74STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    69
    14
    74
    14Y
    DRUG A
    SOC

    GDS02-Memory Problems

    GDS0210

    10

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-15 Minus Glasgow Coma ScoreAPCH11214APACHE IISCREENING1Baseline02020-08-0404AUG2020-13

    3

    GBRNon-North America0
    75STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    70
    15
    75
    15Y
    DRUG A
    SOC

    GDS02-Wonderful to Be Alive

    GDS0211

    11

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    1

    APCH1-A: Total Acute Physiology ScoreAPCH11315APACHE IISCREENING1Baseline02020-08-0404AUG2020-124

    24

    GBRNon-North America0
    DR. JOHN SMITH
    76STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    71

    16
    76
    Y
    Y
    SOC

    DRUG A

    GDS02-Feel Worthless

    GDS0212

    12

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-A: Total Acute Physiology Score - AnalysisAPCH1TPS16APACHE IISCREENING1Baseline02020-08-0404AUG2020-1


    24
    YGBRNon-North America0
    77STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    72
    16
    77
    17Y
    DRUG A
    SOC

    GDS02-Feel Full of Energy

    GDS0213

    13

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    YES

    0

    APCH1-B: Age PointsAPCH11417APACHE IISCREENING1Baseline02020-08-0404AUG2020-165-74YEARS
    5

    GBRNon-North America0
    DR. JOHN SMITH
    78STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    73
    17
    78
    18Y
    DRUG A
    SOC

    GDS02-Feel Hopeless

    GDS0214

    14

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-C: Chronic Health PointsAPCH11518APACHE IISCREENING1Baseline02020-08-0404AUG2020-1for elective postoperative patients

    2

    GBRNon-North America0
    79STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    74
    18
    79
    19Y
    DRUG A
    SOC

    GDS02-Most People Better Off Than You

    GDS0215

    15

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    NO

    0

    DR. JOHN SMITH

    APCH1-Total APACHE II ScoreAPCH11619APACHE IISCREENING1Baseline02020-08-0404AUG2020-131

    31

    GBRNon-North America0
    80STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    80

    20Y
    DRUG A
    SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS
    APCH1TS

    16

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    2013-02-13

    13FEB2013

    90

    3

    Normal

    10

    -7

    Y

    DR. JOHN SMITH
    20APACHE IISCREENING1Baseline02020-08-0404AUG2020-1


    31
    YGBRNon-North America0
    81STUDYXX-
    101
    200-
    P0001
    P0002
    101
    200
    81

    21Y
    DRUG A
    SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS
    APCH1TS

    16

    GDS SHORT FORM

    VISIT 4

    4

    ENDPOINT

    7

    2013-02-13

    13FEB2013

    90

    3

    Normal

    10

    -7

    LOV

    Y

    DR. JOHN SMITH

    Update the below dataset and title according to the current QRS Short_Name instrument.  

    20APACHE II

    Day 15 (Day of Discharge)15
    09AUG20205


    38WOC
    GBRNon-North America0

    APACHE II GDS SHORT FORM Summary Analysis Dataset

    Due to the number of items on the instrument and instrument and the fact that only the total APACHE II score records are required for analysis, the separate summary dataset shown in the following example, which contains only the total APACHE II score records, may also be created.   QSSEQ RSSEQ was not included in this example because it would be null for all computed total score records. QSORRES RSORRES is not shown because only derived total score records are displayed.

    Dataset wrap
    Nameadgdssfsadapchs
    Dataset2
    RowSTUDYIDUSUBJIDSITEIDASEQITTFLTRTPPARAMPARAMCDPARAMNPARCAT1VISITVISITNUMAVISITAVISITNADTADYAVAL
    AVALCAT1
    DTYPE
    BASE
    ABLFL
    CHG
    COUNTRY
    DTYPE
    REGION1
    ABLFL
    REGION1N
    ANL01FL
    20

    1

    STUDYXX-
    101
    100-P0001100
    101
    20YDRUG A + SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS
    APCH1TS

    16

    GDS SHORT FORM

    20APACHE IISCREENING
    VISIT 1
    1
    BASELINE
    Baseline0

    16NOV2012

    1

    10

    Possible Depression

    10

    Y

    Y

    2

    STUDYX

    X-101-P0001

    101

    Y

    DRUG A

    GDS02- Total Score - Analysis

    GDS02TS

    16

    GDS SHORT FORM

    VISIT 2

    2

    VISIT 2

    2

    15DEC2012

    30

    8

    Possible Depression

    10

    -2

    Y

    29JUN2020122
    YUSANorth America1
    40
    3
    STUDYXX-
    101
    100-P0001
    101
    10040YDRUG A + SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS
    APCH1TS

    16

    GDS SHORT FORM

    UNSCHEDULED 2.01

    2.01

    VISIT 2

    2

    28DEC2012

    43

    9

    Possible Depression

    10

    -1

    20APACHE IIDAY 77Day 7705JUL2020714

    USANorth America1
    60
    4
    STUDYXX-
    101
    100-P0001
    101
    10060YDRUG A + SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS

    5

    APCH1TS

    16

    GDS SHORT FORM

    VISIT 3

    3

    VISIT 3

    3

    12JAN2013

    58

    7

    Possible Depression

    10

    -3

    AVERAGE

    Y

    20APACHE IIDAY 1515Day 15 (Day of Discharge)1513JUL2020156

    USANorth America1
    80
    STUDYXX-
    101
    200-
    P0001
    P0002200
    101
    20Y
    DRUG A
    SOC
    GDS02
    APCH1-Total APACHE II Score - Analysis
    GDS02TS
    APCH1TS

    16

    GDS SHORT FORM

    VISIT 4

    4

    VISIT 4

    4

    13FEB2013

    90

    3

    Normal

    10

    -7

    Y

    20APACHE IISCREENING1Baseline004AUG2020-131
    YGBRNon-North America0
    81
    6
    STUDYXX-
    101-P0001

    101

    Y

    DRUG A

    GDS02- Total Score - Analysis

    GDS02TS

    16

    GDS SHORT FORM

    ENDPOINT

    7

    13FEB2013

    90

    3

    Normal

    10

    -7

    LOV

    Y

    7   References

    200-P000220021YSOCAPCH1-Total APACHE II Score - AnalysisAPCH1TS20APACHE II

    Day 15 (Day of Discharge)1509AUG2020538WOC
    GBRNon-North America

    0


    7   References

    1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13(10):818–29. 
    2. Yesavage J. Geriatric depression scale. Stanford/VA/NIA Aging Clinical Research Center (ACRC) Website. Accessed May 6, 2020. http://web.stanford.edu/~yesavage/GDS.html
    3. Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165-173. doi:10.1300/J018v05n01_09

    4. Burke WJ, Roccaforte WH, Wengel SP. The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4(3):173-178. doi:10.1177/089198879100400310

    End of Document